![](/img/cover-not-exists.png)
2035 POSTER NEAT-A: Accelerated sequential epirubicin followed by higher dose 14 day CMF, using pegfilgrastim, is a feasible alternative for delivering dose dense E-CMF chemotherapy in early breast cancer
S. Bowden, L. Gross, C.J. Poole, L. Hiller, R.K. Agrawal, K.F. McAdam, H.M. Earl, S. Anwar, D. ReaVolume:
5
Year:
2007
Language:
english
DOI:
10.1016/s1359-6349(07)70797-8
File:
PDF, 81 KB
english, 2007